Literature DB >> 9589299

Cutaneous manifestations of inflammatory bowel disease.

M Lebwohl1, O Lebwohl.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9589299     DOI： 10.1002/ibd.3780040209

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  16 in total

Review 1.  Biological therapy for dermatological manifestations of inflammatory bowel disease.

Authors:  Maddalena Zippi; Roberta Pica; Daniela De Nitto; Paolo Paoluzi
Journal:  World J Clin Cases       Date:  2013-05-16       Impact factor: 1.337

2.  Extraintestinal manifestations of inflammatory bowel disease.

Authors:  Jonathan S Levine; Robert Burakoff
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-04

3.  Disseminated refractory pyoderma gangraenosum during an ulcerative colitis flare. Treatment with infliximab.

Authors:  Vasiliki A Zampeli; Undine Lippert; Georgios Nikolakis; Evgenia Makrantonaki; Thrasivoulos G Tzellos; Ulf Krause; Christos C Zouboulis
Journal:  J Dermatol Case Rep       Date:  2015-09-30

Review 4.  Cutaneous manifestation of gastrointestinal disease.

Authors:  Maral Rahvar; Justin Kerstetter
Journal:  J Gastrointest Oncol       Date:  2016-04

Review 5.  Crohn's disease and skin.

Authors:  A G Gravina; A Federico; E Ruocco; A Lo Schiavo; F Romano; A Miranda; D Sgambato; M Dallio; V Ruocco; C Loguercio; M Romano
Journal:  United European Gastroenterol J       Date:  2015-08-21       Impact factor: 4.623

Review 6.  Important cutaneous manifestations of inflammatory bowel disease.

Authors:  L B Trost; J K McDonnell
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

7.  Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients.

Authors:  Adam Weizman; Brian Huang; Dror Berel; Stephan R Targan; Marla Dubinsky; Phillip Fleshner; Andrew Ippoliti; Manreet Kaur; Deepa Panikkath; Steve Brant; Ioannis Oikonomou; Rick Duerr; John Rioux; Mark Silverberg; Jerome I Rotter; Eric Vasiliauskas; Talin Haritunians; David Shih; Dalin Li; Gil Y Melmed; Dermot P B McGovern
Journal:  Inflamm Bowel Dis       Date:  2014-03       Impact factor: 5.325

8.  Treatment of pyoderma gangrenosum with infliximab in Crohn's disease.

Authors:  Mark S Sapienza; Sidney Cohen; Anthony J Dimarino
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

9.  Ulcerative colitis presenting as leukocytoclastic vasculitis of skin.

Authors:  Sabiye Akbulut; Ersan Ozaslan; Firdevs Topal; Levent Albayrak; Burcak Kayhan; Cumali Efe
Journal:  World J Gastroenterol       Date:  2008-04-21       Impact factor: 5.742

10.  Pyoderma gangrenosum occurring at the peri-ileal pouch-anal anastomosis in a patient with ulcerative colitis: report of a case.

Authors:  Koji Tanaka; Toshimitsu Araki; Yoshiki Okita; Hiroyuki Fujikawa; Mikio Kawamura; Keiichi Uchida; Yasuhiko Mohri; Masato Kusunoki
Journal:  Surg Today       Date:  2012-12-22       Impact factor: 2.549
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.